2002
DOI: 10.1002/humu.10113
|View full text |Cite
|
Sign up to set email alerts
|

Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies

Abstract: The Marfan syndrome (MFS) is a pleiotropic, autosomal dominant disorder of connective tissue with highly variable clinical manifestations including aortic dilatation and dissection, ectopia lentis, and a series of skeletal anomalies. Mutations in the gene for fibrillin-1 (FBN1) cause MFS, and at least 337 mainly unique mutations have been published to date. FBN1 mutations have been found not only in MFS but also in a range of connective tissue disorders collectively termed fibrillinopathies ranging from mild p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

12
94
2
3

Year Published

2006
2006
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 164 publications
(111 citation statements)
references
References 56 publications
(62 reference statements)
12
94
2
3
Order By: Relevance
“…4 In the majority of patients with classical MFS, a mutation in the FBN1 gene can be identified with, so far, more than 550 different FBN1 mutations being reported that are spread throughout the gene and mostly unique for each family. 5,6 The MFS is known as an autosomal-dominant disorder (MIM 154700) and several studies in human and mice have, for a long time, favored a dominant-negative model for the pathogenesis of MFS. 7 However, recently, based on mice studies a role for a haplo-insuffiency model has been raised, 8 including the hypothesis that abnormal fibrillin or reduced levels of fibrillin may lead to an excess of TGF-b activity.…”
Section: Introductionmentioning
confidence: 99%
“…4 In the majority of patients with classical MFS, a mutation in the FBN1 gene can be identified with, so far, more than 550 different FBN1 mutations being reported that are spread throughout the gene and mostly unique for each family. 5,6 The MFS is known as an autosomal-dominant disorder (MIM 154700) and several studies in human and mice have, for a long time, favored a dominant-negative model for the pathogenesis of MFS. 7 However, recently, based on mice studies a role for a haplo-insuffiency model has been raised, 8 including the hypothesis that abnormal fibrillin or reduced levels of fibrillin may lead to an excess of TGF-b activity.…”
Section: Introductionmentioning
confidence: 99%
“…They have a widespread distribution in nonelastin and elastincontaining tissues, such as the ciliary zonules, blood vessels, lung, and skin, and they act as a lattice for elastin deposition during elastic fiber formation. Mutations in the fibrillin-1 (FBN1) gene cause the connective-tissue disease Marfan syndrome, which is associated with severe cardiovascular, ocular, and skeletal defects (4).…”
mentioning
confidence: 99%
“…4 Second, the broad spectrum of type 1 fibrillinopathies, as well as the wide clinical heterogeneity among individuals and families affected with the same mutation, result in a challenging phenotypic-genotypic correlation. 8,9 Furthermore, extensive phenotypic overlapping is observed in the general population, with high prevalence of MVP or skeletal marfanoid disorders 10,11 and so-called MM conditions. 12,13,14 Finally, whereas this latter group shares $1 clinical features with Marfan syndrome, patients may differ in their clinical evolution and prognosis, showing a low risk of aortic/coronary dilation or dissection.…”
Section: Discussionmentioning
confidence: 99%